2025 annual financial data
Immix Biopharma 2025 Operating margin
Immix Biopharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -29,956,415 USD and net income was -29,438,613 USD.
Operating cash flow was -23,930,304 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -29,956,415 USD
- Net income
- -29,438,613 USD
- Operating cash flow
- -23,930,304 USD